Four years of technology breakthroughs, partnerships and funding milestones.
Our multi-site trial with two university partners has passed its enrollment target. Here is what the interim data is telling us about speed and accuracy in real clinical workflows.
Read more →
A milestone for any medical AI company: independent peer review. We break down the methodology, the results and what comes next.
Read more →
We have raised our first institutional round to scale our platform, expand clinical trials and grow our teams in Baltimore and Oxford.
Read more →
Radiologists will not trust a black box — nor should they. How we built visual explanations and calibrated confidence into every finding.
Read more →
With a second university partner on board, Dinmar Labs launches a prospective, multi-site clinical study spanning two countries.
Read more →
Dinmar Labs crosses the Atlantic. Our new Oxford office puts us at the heart of one of the world's great medical research communities.
Read more →
MRI is a different beast from CT. Here is how we adapted our architecture to multi-sequence brain imaging and early lesion detection.
Read more →
Dinmar Labs signs a research and development agreement with a major U.S. academic medical center to validate our models on real-world data.
Read more →
Great models start with great data. A look inside our de-identification, annotation and quality-control pipeline.
Read more →
Our first outside funding: a competitive innovation grant that will let us expand our dataset and hire our first full-time ML engineers.
Read more →
Six months in, our small team has a working prototype that finds small lung nodules on CT. Here is what we learned building it.
Read more →
Founder Roger Dinmar on the idea that started it all: teaching machines to see what tired human eyes can miss.
Read more →